Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn't work well for some tumors, ...

A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...

Scientists have discovered a potent new antibiotic, pre-methylenomycin C lactone, within a well-studied bacterium, ...

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an ...

Scientists from the University at Albany and NYU Grossman School of Medicine have found a new way to block a harmful process ...

As fall outdoor activities increase, Arkansas residents are being warned about alpha-gal syndrome, a tick-borne illness that ...

Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

Researchers at the Salk Institute have identified a missing molecule, pleiotrophin, as a possible key to repairing faulty brain circuits in Down syndrome. New research indicates that faulty brain circ ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

Just one bite from this insect can lead to a life-long allergy to meat, and you won’t know how bad it is until you munch on a ...

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...